University College London
Personalis MRD Assays to Support UK's TRACERx ctDNA Monitoring Study
The ongoing lung cancer study, which has employed other assays in the past, will now use the Personalis NeXT Personal platform to monitor for recurrence after surgery.
Whole-Genome Sequencing Can Diagnose Neurological Repeat Expansion Disorders, UK Study Finds
The study involved researchers from Queen Mary University of London, University College London, Illumina, and Genomics England and NHS England.
Saga Diagnostics, University College London Cancer Institute Widen Cancer Collaboration
Saga will use its digital PCR-based SagaSafe assays to analyze hundreds of clinical tissue samples from the TRACERx and PEACE studies.
UK Government Partners With More Labs to Lift COVID-19 Testing Capacity
Laboratories at University College London, Imperial College London, Queen Mary University of London, and King's College London will all contribute to the effort.
Greek Researchers Developing Point-of-Care COVID-19 LAMP Assay
The scientists received backing in the form of a €2.4 million EU grant this month and have founded a company, called Biopix-T, to commercialize the platform.